Global Needle-free Injection System Market Share Is Expected to Grow At A CAGR Value Of Around 20.12% By 2028

18-Jan-2023 | Facts and Factors

According to Facts and Factors, the global needle-free injection system market size was worth around USD 129.9 million in 2021 and is predicted to grow to around USD 412.1 million by 2030 with a compound annual growth rate (CAGR) of roughly 20.12% between 2022 and 2030.

The needle-free injection system is a new and revolutionary method developed to eliminate the risks associated with injecting needles in patients for drug delivery. The healthcare and the medical community are looking for more opportunities to adopt these systems to prevent the incorrect ways in which syringes or needles are used while at the same time providing enhanced medical care to the patients.

Browse the full “Needle-free Injection System Market Size, Share, Growth Analysis Report By Application (Insulin Delivery, Vaccine Delivery, Oncology, Pain Management, and Others), By Site of Delivery (Subcutaneous, Intramuscular, and Intradermal), By Usability (Disposable and Reusable), By Technology (Laser-Powered, Jet-Based, Spring-Based, and Vibration-Based), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030" report at https://www.fnfresearch.com/needle-free-injection-system-market

These methods have proven to be very effective methods in injecting a wide variety of bioequivalent drugs and the major reason why they are preferred amongst patients is that needle-free injections are free of pain. Other benefits associated with the use of needleless injection systems include faster drug delivery and zero requirements of having a needle disposable system in place.

The global market is witnessing a surge in interest from various players because it is capable of not only benefitting the pharmaceutical industry but the approach is very patient-oriented as well since it can improve the rate of medicine compliance for those who follow a regular dosage regimen like diabetic patients. Needle-free injection methods can inject liquid drugs as well as solid medicines making them more versatile than needle-based injections that only allow the administration of liquid drugs. Various ways are used in the needle-free injection system where some are laser-based and some may be pressure-based

The global needle-free injection system market is projected to grow due to the growing number of harmful incidents associated with needle-injecting systems. Once a needle is used in a patient it is mandatory that the needle is safely discarded. In such situations, there is always a chance of human error and the same needle may be used on a different patient. This could potentially prove to be fatal in many circumstances and is one of the major ways HIV AIDS has spread over the years. Poorly trained medical professionals, lack of knowledge, or negligence are the reasons why there has been a growth in the number of reported cases where injections were improperly used.

As per estimated, around 8000 to 9000 people in the US die due to medical errors. Such factors have led the medical community to look for ways of administering drugs that are less risky and involve minimal human intervention in terms of injecting the medicine. The global market may further be driven by the growing number of medical waste generated from the use of disposable needles and the difficulty associated with installing proper disposal systems leading to a shift toward adopting methods that altogether eliminate the need of creating the need to dispose of used medical waste,

The global market may face growth restrictions due to the absence of required medical infrastructure in many countries. Needle-free injection systems are relatively new in the medical industry and their operation requires trained professionals. As many economies currently lack basic health infrastructure, they do not have the right training institutes which results in a lack of skilled staff posing as a major roadblock during the global market expansion period.

The growing investments in healthcare may provide growth opportunities while problems with pressure mechanisms are expected to challenge market growth.

Segmental Overview

The global needle-free injection system market is segmented based on application, site of delivery, usability, technology, and region

Based on site of delivery, the global market segments are subcutaneous, intramuscular, and intradermal. The global market registered the highest growth in the subcutaneous segment in 2021 as the medicines delivered in the capillaries are known to show the outcome as they can be easily carried along with the bloodstream. It is the preferred way to administer insulin, vaccine, or growth hormones. The insulin market was valued at USD 18 billion in 2021.

Based on technology, the global market divisions are laser-powered, jet-based, spring-based, and vibration-based. The laser-powered segment was the most dominating in 2021 due to growing innovations and development in laser-based technology. This system uses a liquid jet that is shot through a laser in the patient. The Pharmajet injectors cost around USD 100 per pop.

Regional Overview 

North America is anticipated to lead the global needle-free injection system market owing to higher product penetration as well as a growing number of chronic patients. In the US, heart conditions, diabetes, and cancer are the leading causes of death.

As per the official report, more than 697,000 Americans are known to suffer from fatal coronary problems and 1 in every 5 deaths is due to heart failure. On average, around 84900 people have a heart attack annually in the US. Growth in Asia-Pacific is projected to be driven by the growing investments in the healthcare sector to meet the increasing demand of the population. In 2019, Japan’s spending on healthcare per capita stood at USD 4360.

Report Scope

Competitive Landscape

The global needle-free injection system market is led by players like Medical International Technology, Inc., European Pharma Group, Endo International plc, Bioject Medical Technologies Inc., and PenJet Corporation amongst others.

Recent Developments:

• In September 2022, PharmaJet, a producer of commercially available needle-free injection platform, was all set to show its research findings on the impact of its needle-free injection systems on immunogenicity
• In March 2022, NovaXS Biotech reported its intention to develop the injection therapy to go needle-free. The company intended to seek USD 1.5 million in seed funding to make its vision a reality

The global needle-free injection system market is segmented as follows:

By Application

• Insulin Delivery
• Vaccine Delivery
• Oncology
• Pain Management
• Others

By Site of Delivery

• Subcutaneous
• Intramuscular
• Intradermal

By Usability

• Disposable
• Reusable

By Technology

• Laser-Powered
• Jet-Based
• Spring-Based
• Vibration-Based

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com